Tarsier Pharma Seeks Public Listing on New York Stock Exchange

Tarsier Pharma, a biopharmaceutical company, has initiated the process to become a publicly traded entity. The firm aims to list its shares on the New York Stock Exchange under the proposed ticker symbol "TARX."

Tarsier Pharma, a biopharmaceutical firm focused on developing innovative treatments, is taking steps toward entering the public market. The company has formally submitted an application for an initial public offering (IPO) on the New York Stock Exchange, according to a recent disclosure reported by Investing.com. This move signifies Tarsier Pharma's intention to raise capital through the sale of its shares to the public. Upon successful completion of the offering, the company's stock is expected to trade under the symbol